The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 18, 2012, Pages 7031-7036

  Kang, Rui ^a   Loux, Tara ^a   Tang, Daolin ^a   Schapiro, Nicole E ^a   Vernon, Philip ^a   Livesey, Kristen M ^a   Krasinskas, Alyssa ^b   Lotze, Michael T ^a   Zeh III, Herbert J ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Bioenergetics; High mobility group box 1; Inflammation; Metabolism; Oncogenesis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CARCINOGENESIS; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTOPHAGY; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-6; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MITOCHONDRIA; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR MICROENVIRONMENT;

MURINAE; MUS;

EID: 84860813449     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113865109     Document Type: Article

References (33)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236.
2. Hruban RH, Adsay NV (2009) Molecular classification of neoplasms of the pancreas. Hum Pathol 40:612-623.
3. Hingorani SR, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4:437-450. (Pubitemid 38050041)
4. Gebhardt C, et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205:275-285. (Pubitemid 351281593)
5. Taguchi A, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360. (Pubitemid 30337069)
6. Kang R, et al. (2011) The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid Redox Signal 15: 2175-2184.
7. Kang R, et al. (2010) The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 17:666-676.
8. Yang Z, Klionsky DJ (2010) Eaten alive: A history of macroautophagy. Nat Cell Biol 12: 814-822.
9. Rabinowitz JD, White E (2010) Autophagy and metabolism. Science 330:1344-1348.
10. Tang D, Lotze MT, Kang R, Zeh HJ (2011) Apoptosis promotes early tumorigenesis. Oncogene 30:1851-1854.
11. Fujii S, et al. (2008) Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99:1813-1819.
12. Yang S, et al. (2011) Pancreatic cancers require autophagy for tumor growth. Genes Dev 25:717-729.
13. Lesina M, et al. (2011) Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19:456-469.
14. Wegrzyn J, et al. (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793-797.
15. Tang D, et al. (2011) High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab 13:701-711.
16. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140:313-326.
17. Kuma A, et al. (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032-1036. (Pubitemid 40052234)
18. Hanada T, et al. (2007) The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 282:37298-37302.
19. Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
20. Sparvero LJ, et al. (2009) RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7:17.
21. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 9:798-809.
22. Bromberg J, Wang TC (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15:79-80.
23. Okada S, et al. (1998) Elevated serum interleukin-6 levels in patients with pancreatic cancer. Jpn J Clin Oncol 28:12-15. (Pubitemid 128527476)
24. Fukuda A, et al. (2011) Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19:441-455.
25. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367-388.
26. Gough DJ, et al. (2009) Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324:1713-1716.
27. Liang XH, et al. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402:672-676. (Pubitemid 129516338)
28. Takamura A, et al. (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25:795-800.
29. Altman BJ, et al. (2011) Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 30:1855-1867.
30. Lock R, et al. (2011) Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22:165-178.
31. Guo JY, et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460-470.
32. Kang R, Tang D, Loze MT, Zeh HJ (2011) Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE). Autophagy 7:91-93.
33. DiNorcia J, et al. (2012) RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J Gastrointest Surg 16:104-112, discussion 112.